findmyKOL
Clinical trialNCT04772547CompletedPhase 2Interventional

VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa

SponsorUniversity of FloridaEnrollment6ComaStatus Epilepticus, Electrographic
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a pilot trial of a single loading dose of vigabatrin in post-anoxic status epilepticus.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Florida

    Gainesville, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Vigabatrin Only Product
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Sept 2021
Primary completion
7 Jun 2023
Completion
23 Jan 2024
Last update posted
23 Jul 2024
Registered enrollment
6
Registry id
NCT04772547

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.